CRH Medical Corp (CVE:CRM) Senior Officer James Kreger sold 9,900 shares of CRH Medical stock in a transaction on Monday, August 17th. The stock was sold at an average price of C$3.75, for a total transaction of C$37,144.80. Following the sale, the insider now directly owns 53,600 shares of the company’s stock, valued at approximately C$201,107.20.
CRH Medical Corp has a fifty-two week low of C$83.00 and a fifty-two week high of C$128.87.
About CRH Medical
CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company’s lead product, the CRH O’Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV.
Featured Story: What is an Initial Public Offering (IPO)?
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.